Form F-3 - Registration statement by foreign private issuers:
SEC Accession No. 0001062993-25-014903
Filing Date
2025-08-26
Accepted
2025-08-25 18:53:30
Documents
19

Document Format Files

Seq Description Document Type Size
1 FORM F-3 formf3.htm F-3 374037
2 EXHIBIT 1.2 exhibit1-2.htm EX-1.2 198879
3 EXHIBIT 5.1 exhibit5-1.htm EX-5.1 39091
4 EXHIBIT 23.1 exhibit23-1.htm EX-23.1 1955
5 EXHIBIT FILING FEES exhibitfilingfees.htm   iXBRL EX-FILING FEES 32257
6 GRAPHIC exhibit5-1xu001.jpg GRAPHIC 3721
7 GRAPHIC exhibit23-1xu001.jpg GRAPHIC 12049
8 GRAPHIC formf3x002.jpg GRAPHIC 6963
9 GRAPHIC formf3x003.jpg GRAPHIC 7999
  Complete submission text file 0001062993-25-014903.txt   821338

Data Files

Seq Description Document Type Size
21 EXTRACTED XBRL INSTANCE DOCUMENT exhibitfilingfees_htm.xml XML 8041
Mailing Address 19 VESTRY STREET NEW YORK NY 10013
Business Address 19 VESTRY STREET NEW YORK NY 10013 6474072515
BRIGHT MINDS BIOSCIENCES INC. (Filer) CIK: 0001827401 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0930
Type: F-3 | Act: 33 | File No.: 333-289851 | Film No.: 251252268
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)